FIELD: medicine.
SUBSTANCE: while examination, the patient is scored for 4 reliable informative factors reflecting separate pathophysiological sensitisation mechanisms: general IgE blood plasma level; eosinophilia in peripheral blood film; eosinophilia in nasal smear; positive skin scratch tests with any of 6 allergens (house dust mites of 2 kinds, library dust mites; mould; animal epidermis: a cat, a dog). Derived scores are summarised to obtain the integrated sensitisation index (ISI) which being 4 to 6 shows intermittent BA not requiring regular basic therapy. If the ISI is within 7 to 9, persistent BA is diagnosed with obligatory prescribed inhalation steroids required.
EFFECT: method allows for reliable estimation of asthma severity, well-timed treatment tactics that substantially ensures favourable clinical outcome.
1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DETERMINING SEVERITY OF BRONCHIAL ASTHMA IN CHILDREN | 2011 |
|
RU2469328C1 |
| METHOD FOR ASSESSING THE SEVERITY OF BRONCHIAL ASTHMA EXACERBATION USING AN INTEGRAL INDICATOR | 2021 |
|
RU2765432C1 |
| METHOD FOR DETECTING SENSITIZATION TO ALLERGENS | 2002 |
|
RU2223498C1 |
| METHOD FOR PREVENTING BRONCHIAL ASTHMA IN CHILDREN WITH RECURRENT LARYNGOTRACHEITIS AND ASSOCIATED ALLERGIC DISEASES | 2020 |
|
RU2757845C1 |
| METHOD OF PREDICTING DEVELOPMENT OF POLLEN BRONCHIAL ASTHMA | 2010 |
|
RU2433408C1 |
| METHOD FOR PREDICTING ALLERGY TO CONCRETE ALLERGEN | 2002 |
|
RU2222814C1 |
| METHOD FOR PREDICTING THE SEVERE COURSE OF BRONCHIAL ASTHMA IN CHILDREN | 2021 |
|
RU2764364C1 |
| METHOD OF TREATING CHRONIC RECURRENT ALLERGIC DISEASES OF NASAL MUCOSA AND PARANASAL SINUSES BY ENDONASAL AUTOLYMPHOCYTE THERAPY | 2009 |
|
RU2411048C1 |
| METHOD FOR SELECTING TARGETED THERAPY IN CHRONIC T2-INFLAMMATORY DISEASES OF NASAL CAVITY AND PARANASAL SINUSES | 2023 |
|
RU2824263C1 |
| METHOD FOR DETERMINING FUNCTIONAL ACTIVITY OF PHAGOCYTES IN THE CASES OF ALLERGY | 2002 |
|
RU2225984C1 |
